Bayer May Cut U.S. Sales Force After Cipro Generics Enter Market

Bayer is looking to make further cuts in its U.S. pharmaceutical division following entry of Cipro generics, Bayer Health Care Chairman Arthur Higgins said during an earnings conference Aug. 3

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet